Topiramate
Product Images NDC 16590-825

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 16590-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (25 mg)

Topiramate 25 mg tablet bottle label with 30 tablets, labeled by STAT Rx USA LLC. The label states the product is generic for Topiramate, with NDC 16590-824-30, manufactured by Torrent Pharma Inc. Dosage and storage instructions, lot number, and cautionary warning about drowsiness or dizziness are included.*

FDA Label Image

Label Image (50 mg)

Label for Topiramate 50 mg tablets, 30 count, manufactured by Torrent Pharma Inc. The label includes the NDC number 16590-825-30 and indicates the product contains 50 mg of Topiramate per tablet. It features warnings about potential drowsiness or dizziness and instructions to keep the medication out of reach of children. The label also displays the distributor as STAT Rx USA LLC and provides storage and discard information.*

FDA Label Image

Label Image (100 mg)

Topiramate 100mg tablet bottle label showing 60 tablets. Packaged and distributed by STAT Rx USA in Gainesville, GA. The label includes the NDC 16590-817-60 and notes the tablets contain 100mg of Topiramate USP each. Manufacturer is Torrent Pharma Inc., Kalamazoo, MI. A yellow warning strip states the medication may cause drowsiness or dizziness.*

FDA Label Image

Image (Topiramate Figure 01)

Chemical structure diagram of the active ingredient Topiramate, showing its molecular configuration with labeled atoms and functional groups.*

FDA Label Image

Image (Topiramate Figure 02)

A Kaplan-Meier curve chart depicting cumulative rates for time to first seizure over 500 days for Topiramate at doses of 50 mg/day and 400 mg/day. The x-axis shows time in days, and the y-axis shows cumulative seizure rates. The graph compares 234 subjects on 50 mg/day versus 236 subjects on 400 mg/day, with a p-value of 0.0002 indicating statistical analysis.*

FDA Label Image

Logo (Topiramate Figure 03)

FDA Label Image

Logo (Topiramate Figure 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.